Talk:Biovest

This article is rated C-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Companies Low‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles

Low This article has been rated as Low-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Technology

This article is within the scope of WikiProject Technology, a collaborative effort to improve the coverage of technology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.TechnologyWikipedia:WikiProject TechnologyTemplate:WikiProject TechnologyTechnology articles

I think the content of this article is highly questionable. Nobody really knows what has become of Biovaxid and - after a lot of legal and financial calamities - of the company. It simply sounded to good in the beginning and some scientists gave their name to promote the product. Later it became clear that the good results of the trials were not reliable.

- - - — Preceding unsigned comment added by Atemkristall (talk • contribs) 18:11, 30 April 2020 (UTC)[reply]

Why do you want to delete the article? The company may be important because it is developing a new class of drug called a cancer vaccine. The first cancer vaccine was recently approved by a competitor (Dendreon's Provenge drug). Just like Rituximab was the first anti-cancer monoclonal antibody approved for cancer (in 1997), Dendreon's Provenge for Prostate Cancer is the first FDA approved cancer vaccine. This company, Biovest, has already completed a phase III trial for it's follicular lymphoma drug BiovaxID, which is also a cancer vaccine.

If you want me to add more to this article, I will when I have time.

Article Name[edit]

I'm pretty sure "Biovaxid" should be the primary article, and "Biovest" a redirect to it, rather than the other way round as it is at present. What do you think? Thparkth (talk) 01:27, 2 May 2010 (UTC)[reply]

Not sure that makes sense... Biovaxid is a product of biovest... having biovest redirect to biovaxid is like having walmart GE redirect to ultrasound... right now it's their prime product but still nonsensical —Preceding unsigned comment added by 69.153.131.53 (talk) 06:29, 4 May 2010 (UTC)[reply]

Response[edit]

Feel free to change the redirects or anything else. I just wanted to create a basic page about BiovaxID and Biovest.

Contested deletion[edit]

This article should not be speedily deleted for lack of asserted importance because I added BiovaxID intro, manufacturing, data, indications, and company patents. — TiantongQ (talk) 07:35, 3 December 2011 (UTC)[reply]